arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Tenax Therapeutics, Inc.

TENX Health Care Biotechnology: Pharmaceutical Preparations
$1.94
Today
as of Sep 4, 16:55 ET
Last 30 days -88.02% Jul 27 → Sep 04
$0.19 $4.49 $8.78 $13.08 $17.38 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$1.82
High
$1.96
Low
$1.80
Volume
$4M
Avg Vol
$1M
Mkt Cap
$67M
P/E (TTM)
—
Beta
—
52w High
$19.40
52w Low
$1.31
Div Yield
—
Shares Out
$32M

Recent Press Releases & News last 60 days · 17 items

Sep 4 · 22:26 Insider Monkey
Tenax (TENX) Found a 26.3-Meter Benefit in a Prespecified Subgroup After LEVEL Missed Its Primary Endpoint. Is Another Phase 3 Trial Viable?
Sep 1 · 11:00 PR GlobeNewswire
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
Aug 31 · 10:29 MT Newswires
Guggenheim Downgrades Tenax Therapeutics to Neutral From Buy
▸ Show all 17 press releases & news Free account →

Overview

52-week range
$1.31
$19
3% of range
Avg surprise (last 3)
+33.4%
Avg reaction (last 2)
+1.0%
100% positive
Latest IV / EM
91%
EM ±14.2% · $2 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.12$-2.39$-1.66$-0.92$-0.19 Actual $-3.12Actual $-1.83Actual $-0.19Actual $-0.28Est $-0.48Actual $-0.27Est $-0.50Actual $-0.40Actual $-0.35Est $-0.40Actual $-0.35 MarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-18M$-14M$-11M$-8M$-4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.35 — — — — financials
Tue May 12, 2026Mar/2026 $-0.35 $-0.40 +12.5% -25.0% +1.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.40 — — — — financials
Wed Aug 13, 2025Jun/2025 $-0.27 $-0.50 +46.0% — — earnings
Wed May 14, 2025Mar/2025 $-0.28 $-0.48 +41.7% — +0.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.19 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1.83 — — — — financials
Sun Mar 31, 2024Mar 2024 $-3.12 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue—$0———$0——
Cost of revenue————————
Gross profit————————
Operating income$-19M$-17M—$-17M$-12M$-11M—$-5M
Net income$-18M$-16M—$-16M$-11M$-10M—$-4M
EPS (diluted)$-0.35$-0.35—$-0.40$-0.27$-0.28—$-0.19

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$118M$119M—$99M$106M$111M——
Inventory————————
Total current assets$122M$123M$104M$103M$106M$112M$97M$100M
Total assets$122M$123M$104M$103M$106M$112M$97M$100M
Long-term debt————————
Total liabilities$8M$8M$7M$7M$3M$3M$5M$3M
Total equity$114M$115M$97M$96M$103M$109M$92M$97M

Implied volatility — last 90 days

60%513%966%1419%1872% Jun 08 — IV 341% · EM ±45.1%Jun 09 — IV 361% · EM ±45.2%Jun 10 — IV 384% · EM ±45.3%Jun 11 — IV 383% · EM ±42.3%Jun 12 — IV 145% · EM ±14.8%Jun 15 — IV 206% · EM ±14.9%Jun 16 — IV 250% · EM ±14.8%Jun 17 — IV 373% · EM ±15.6%Jun 19 — IV 74% · EM ±16.2%Jun 22 — IV 83% · EM ±17.3%Jun 23 — IV 82% · EM ±16.7%Jun 24 — IV 119% · EM ±23.8%Jun 25 — IV 72% · EM ±14.2%Jun 26 — IV 86% · EM ±16.4%Jun 29 — IV 61% · EM ±10.7%Jun 30 — IV 106% · EM ±18.2%Jul 01 — IV 80% · EM ±13.4%Jul 02 — IV 67% · EM ±10.9%Jul 03 — IV 68% · EM ±10.7%Jul 06 — IV 130% · EM ±18.0%Jul 10 — IV 139% · EM ±15.4%Jul 13 — IV 240% · EM ±20.0%Jul 14 — IV 444% · EM ±32.1%Jul 16 — IV 373% · EM ±15.6%Jul 20 — IV 328% · EM ±77.5%Jul 21 — IV 339% · EM ±78.9%Jul 22 — IV 390% · EM ±89.3%Jul 23 — IV 404% · EM ±90.8%Jul 24 — IV 444% · EM ±98.1%Jul 27 — IV 461% · EM ±96.4%Jul 28 — IV 450% · EM ±92.1%Jul 29 — IV 460% · EM ±92.1%Jul 30 — IV 433% · EM ±84.8%Jul 31 — IV 450% · EM ±86.1%Aug 03 — IV 534% · EM ±94.6%Aug 04 — IV 566% · EM ±97.5%Aug 05 — IV 528% · EM ±88.1%Aug 06 — IV 533% · EM ±86.2%Aug 07 — IV 638% · EM ±99.6%Aug 10 — IV 1109% · EM ±153.6%Aug 11 — IV 846% · EM ±111.7%Aug 12 — IV 751% · EM ±94.1%Aug 13 — IV 368% · EM ±43.5%Aug 14 — IV 672% · EM ±74.2%Aug 17 — IV 1085% · EM ±90.6%Aug 18 — IV 1317% · EM ±95.2%Aug 19 — IV 1081% · EM ±63.8%Aug 20 — IV 1873% · EM ±78.2%Aug 24 — IV 220% · EM ±45.9%Aug 25 — IV 104% · EM ±21.4%Aug 26 — IV 130% · EM ±26.1%Aug 27 — IV 140% · EM ±27.4%Aug 28 — IV 140% · EM ±26.9%Aug 31 — IV 239% · EM ±42.3%Sep 01 — IV 419% · EM ±72.2%Sep 02 — IV 460% · EM ±76.8%Sep 03 — IV 442% · EM ±71.4%Sep 04 — IV 91% · EM ±14.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in